Pentagon Orders Development of Vaccine for AIRBORNE Ebola.
•Profectus BioSciences Receives $9.5 Million Department of Defense Funding to Manufacture Trivalent VesiculoVax™-Vectored Vaccine to Protect Against all Ebola and Marburg Viruses – Funding to support GMP manufacture of VesiculoVax™-vectored v